Groww IPO
mainboardListed
GMP
₹4

mainboardListed
Groww IPO
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹4
(+4.00%) Est. Gain
Investment Timeline
✓
IPO Open
4 Nov 2025
✓
IPO Close
7 Nov 2025
✓
Allotment
10 Nov 2025
✓
Listing
12 Nov 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
AVOID
43.8/100
🎯 Application Strategy
Action: ⛔ AVOID - Better opportunities available elsewhere
Lots: NOT RECOMMENDED
⏳ Timing Advice
✅ Apply by DAY 2-3 - Moderate demand, reasonable allotment probability
Key Factor Analysis
🚀
Demand
✅ Good subscription levels indicate positive market sentiment
💰
Valuation
⚠️ Expensive valuation - limited room for gains
📈
Listing
⚠️ Limited listing gains expected (0-5%)
📊
Financials
👍 Solid financial performance with stable fundamentals
Issue Details
🏷️Price Band
₹95.0 - ₹100.0
📦Lot Size
150 shares
💰Issue Size
₹6632.30 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Groww IPO?
As of today, the Grey Market Premium (GMP) for Groww IPO is ₹4, which is approximately (+4.00%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Groww IPO?
Our AI algorithm currently rates this IPO as "AVOID" with a score of 43.8/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Groww IPO be announced?
The allotment status for Groww IPO is expected to be finalized on 10 Nov 2025. Investors can check their status on the registrar's website.
What is the listing date for Groww IPO?
Shares of Groww IPO are proposed to be listed on stock exchanges on 12 Nov 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.